8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2014 / Double-blinded randomized clinical trial
In a double-blind trial, 100 individuals experiencing acute migraine without aura were randomized to receive ginger powder or sumatriptan. Two hours after administration, both treatments significantly lowered headache severity with similar efficacy. Ginger powder produced fewer clinical side effects than sumatriptan, while patient satisfaction and willingness to continue therapy were comparable after one month.
Maghbooli M, Golipour F, Moghimi Esfandabadi A, et al. Phytother Res, 2014. PMID 23657930
2014 / Three-arm intervention trial
Participants trying to reduce chocolate intake (n = 137) were allocated to use cognitive defusion, acceptance, or relaxation (control) techniques over 5 days while carrying a bag of chocolates and logging their intake. Compared to controls, participants using cognitive defusion ate significantly less chocolate from the bag (p = .046) and less chocolate based on diaries (p = .053), with evidence linking this to reduced automaticity of chocolate consumption. No differences in chocolate consumption were found between the acceptance and control groups.
Jenkins KT, Tapper K Br J Health Psychol, 2014. PMID 23678870
2014 / Randomized controlled trial
Healthy adults aged >=50 years were randomly assigned to exercise (n=47), MBSR (n=51), or a waitlist control condition (n=51) and received trivalent inactivated influenza vaccine after 6 weeks. No differences in vaccine responses were found between the control group and the MBSR or exercise groups. However, individuals achieving seroprotective antibody levels (>=160 units) had higher optimism, less anxiety, and lower perceived stress, while age correlated with antibody responses.
Hayney MS, Coe CL, Muller D, et al. Hum Vaccin Immunother, 2014. PMID 24096366
2014 / Randomized controlled trial
A clinical trial randomized 105 cognitively intact adults aged 65 to 85 years to receive either the NT-020 nutraceutical (n=52) or placebo (n=53) for two months. Participants receiving the supplement showed significant improvements on two tests of processing speed compared to the placebo group. Scores across five other evaluated cognitive areas did not differ between treatment groups, and adverse event rates were similar.
Small BJ, Rawson KS, Martin C, et al. Rejuvenation Res, 2014. PMID 24134194
2014 / Randomized controlled trial
A randomized trial assigned 48 children aged 3 to 10 years with autism to receive 200 mg daily of DHA or placebo for 6 months. Despite a median 431% surge in total plasma DHA, core autism symptoms on the Clinical Global Impressions-Improvement scale did not differ between cohorts. Parents reported superior social skills in the placebo group (P = 0.04), whereas teachers reported better functional communication with DHA (P = 0.02).
Voigt RG, Mellon MW, Katusic SK, et al. J Pediatr Gastroenterol Nutr, 2014. PMID 24345834
2014 / Counterbalanced Latin square crossover experimental study
Forty-seven healthy college students completed four breathing patterns combining two rates (6 and 5.5 breaths per minute) and two inhalation-to-exhalation ratios (5:5 and 4:6) using a counterbalanced Latin square design. A breathing pattern of 5.5 breaths per minute with an inhalation-to-exhalation ratio of 5:5 yielded a higher NN interval standard deviation and higher low frequency power than the other patterns. Additionally, all four breathing patterns significantly increased feelings of relaxation compared with baseline.
Lin IM, Tai LY, Fan SY Int J Psychophysiol, 2014. PMID 24380741
2014 / Double-blind, placebo-controlled randomized clinical trial
A randomized trial investigated the effects of 2000 IU/d of alpha tocopherol, 20 mg/d of memantine, their combination, or placebo in 613 patients with mild to moderate Alzheimer disease over a mean follow-up of 2.27 years. Over follow-up, ADCS-ADL scores declined by 3.15 units less in the alpha tocopherol group compared with placebo (95% CI, 0.92 to 5.39; adjusted P = .03), corresponding to an annualized 19% delay in clinical progression. Decline in the memantine group was not significantly different from placebo (1.98 units less; 95% CI, -0.24 to 4.20; adjusted P = .40), nor were significant differences seen for combination therapy. Caregiver time increased least with alpha tocopherol, while serious adverse events for infections or infestations were higher in the memantine and combination groups compared with placebo.
Dysken MW, Sano M, Asthana S, et al. JAMA, 2014. PMID 24381967
2014 / Randomized controlled trial
A randomized trial evaluated 270 pregnant women receiving 400 mg/day DHA or placebo from 16 weeks gestation to delivery. Infants in the placebo group had increased risk of poorer language scores at 14 months (words understood OR 3.22, CL 1.49-6.94; words produced OR 2.61, CL 1.22-5.58) and 18 months, as well as lower visual acuity at 2 months (OR 2.69, CL 1.10-6.54).
NANO counterpoint →
Mulder KA, King DJ, Innis SM PLoS One, 2014. PMID 24427279
2014 / Randomized crossover trial
Twenty-five young, healthy adults consumed 355 mL of Red Bull or water in a crossover protocol. Red Bull intake increased systolic and diastolic blood pressure (p < 0.005), heart rate, and cardiac output (p < 0.05), while elevating myocardial load and cerebrovascular resistance (p < 0.005). The energy drink also caused significant drops in end-tidal carbon dioxide levels and the speed of cerebral blood flow (p < 0.005).
Grasser EK, Yepuri G, Dulloo AG, et al. Eur J Nutr, 2014. PMID 24474552
2014 / Randomized controlled trial
This study compared the efficacy of two-week mindfulness-based interventions targeting different combinations of mindfulness skills (awareness, acceptance, disidentification) against an active control intervention (distraction) for reducing chocolate cravings. Disidentification was the most efficacious skill; participants trained in disidentification reported less intense state cravings following a craving induction task compared to those trained in distraction. This effect was mediated by an increase in disidentification skill and a subsequent decrease in trait chocolate cravings.
Lacaille J, Ly J, Zacchia N, et al. Appetite, 2014. PMID 24503333
2014 / Randomized controlled trial
Mothers were randomly allocated to receive 800 mg DHA/d or placebo from ~20 weeks of gestation until birth, and 158 term-born children completed assessments at a mean of 27 ± 2 months. There was no effect of supplementation on primary outcomes, including distractibility (mean difference: -0.2 s; 95% CI: -0.7, 0.4 s) and WMIC (mean difference: 8.9 mm; 95% CI: -10.6, 28.3 mm). Treatment children looked away from toys fewer times with competing toys but less accurately remembered a repeated hiding location, which was not consistent with other outcomes and may have been due to chance.
Gould JF, Makrides M, Colombo J, et al. Am J Clin Nutr, 2014. PMID 24522442
2014 / Randomized crossover trial
A randomized crossover trial in 30 healthy adults compared the acute effects of apple, spinach, apple plus spinach, and control. All treatments raised plasma RXNO compared to control, and spinach treatments significantly increased plasma, salivary, and urinary nitrate and nitrite. Neither apples, spinach, nor their combination caused significant acute improvements or decrements in cognitive performance or mood.
Bondonno CP, Downey LA, Croft KD, et al. Food Funct, 2014. PMID 24676365
2014 / Randomized crossover trial
A randomized double-blind crossover trial tested three-day challenges of gluten (16 grams per day), whey, or placebo in 22 adults with irritable bowel syndrome controlled on a gluten-free diet. Gluten ingestion caused higher state depression scores compared with placebo (mean difference 2.03, 95% CI 0.55 to 3.51, P = 0.010), but not compared with whey. Cortisol levels and gastrointestinal symptoms did not differ across the three challenges.
Peters SL, Biesiekierski JR, Yelland GW, et al. Aliment Pharmacol Ther, 2014. PMID 24689456
2014 / Crossover trial
Healthy adults consumed a study-prepared high-aspartame diet (25 mg/kg body weight/day) for 8 days and a low-aspartame diet (10 mg/kg body weight/day) for 8 days, separated by a 2-week washout period. Participants were evaluated for within-subject differences in mood, depression, headaches, and cognitive tests of working memory and spatial orientation. When consuming the high-aspartame diet, participants experienced more irritable mood, exhibited more depression, and performed worse on spatial orientation tests. Aspartame consumption did not affect working memory.
Lindseth GN, Coolahan SE, Petros TV, et al. Res Nurs Health, 2014. PMID 24700203
2014 / Randomized controlled trial (secondary analysis)
A total of 107 frail, obese older adults were randomized to a control, diet, exercise, or diet-plus-exercise group for 1 year. 3MS cognition scores improved more in the diet (mean ± SE: 1.7 ± 0.4), exercise (2.8 ± 0.4), and diet-exercise (2.9 ± 0.4) groups than in the control group (0.1 ± 0.4; between-group P = 0.0001-0.04), with diet-exercise improving more than diet but not exercise alone. IWQOL scores also improved more in the diet (7.6 ± 1.6), exercise (10.1 ± 1.6), and diet-exercise (14.0 ± 1.4) groups than control (0.3 ± 1.6; P = 0.0001-0.03), again with diet-exercise showing greater improvement than diet alone but not exercise alone. Word Fluency and Trail Making Test scores also improved with exercise-containing interventions, while Geriatric Depression Scale scores did not change.
Napoli N, Shah K, Waters DL, et al. Am J Clin Nutr, 2014. PMID 24787497
2014 / Randomized crossover trial
In a randomized, double-blind crossover trial, 27 participants with type 2 diabetes consumed beetroot juice providing 7.5 mmol nitrate daily or nitrate-depleted placebo juice for two weeks each. Simple reaction time was significantly faster after nitrate supplementation (327 ± 40 ms) than after placebo (341.8 ± 52.7 ms; mean difference 13.9 ± 25.6 ms, 95% CI 3.8 to 24.0 ms, p = 0.009). No other cognitive function tests showed significant differences between treatments.
Gilchrist M, Winyard PG, Fulford J, et al. Nitric Oxide, 2014. PMID 24858657
2014 / Randomized controlled trial
A randomized, double-blind, placebo-controlled trial tested daily folic acid (2.5 mg) against placebo for up to 36 months in 112 youth aged 14 to 24 years at familial risk for mood disorders. Mood disorder incidence occurred in 14.3% of the folic acid group and 17.9% of the placebo group, demonstrating no statistically significant difference between treatments. Folic acid was well tolerated, though trial power was limited by sample size and lower-than-anticipated incidence rates.
Sharpley AL, Hockney R, McPeake L, et al. J Affect Disord, 2014. PMID 25010374
2014 / Randomized crossover trial
In a randomized, single-blind crossover trial, 14 healthy young men received eight days of daily anodal transcranial direct current stimulation of the right dorsolateral prefrontal cortex or sham stimulation. Following one week of active stimulation, participants significantly reduced buffet caloric intake by 14% compared to sham. Active brain stimulation also lowered self-reported appetite scores.
Jauch-Chara K, Kistenmacher A, Herzog N, et al. Am J Clin Nutr, 2014. PMID 25099550
2014 / Randomized controlled trial
In a 12-month double-blind trial, 68 patients with moderate to severe Alzheimer's disease received either 30 mg daily of saffron extract or 20 mg daily of memantine. Changes on the Severe Cognitive Impairment Rating Scale (P = 0.38) and Functional Assessment Staging (P = 0.87) did not differ significantly between treatments. Adverse event rates were also comparable between the two interventions.
Farokhnia M, Shafiee Sabet M, Iranpour N, et al. Hum Psychopharmacol, 2014. PMID 25163440
2014 / Randomized crossover trial
In 24 healthy adults, consuming a deep-fried Mars bar produced a non-significant reduction in cerebrovascular reactivity compared to porridge (mean difference in absolute Breath Holding Index -0.11, p=0.40). No overall difference occurred across the full sample, though a modest reduction was noted in males. A significant difference in absolute change appeared between genders (mean difference women minus men 0.65, 95% CI 0.30 to 1.00, p=0.0003).
Dunn WG, Walters MR Scott Med J, 2014. PMID 25246421
2014 / Pilot clinical trial
In a pilot clinical trial, 40 depressive menopausal women were divided into four groups of 10 and received fluoxetine (10 mg), soybean (100 mg), sertraline (50 mg), or sertraline (50 mg) plus soybean (100 mg) for three months. All treated groups showed significant improvement compared to their pre-treatment baseline on both the Hamilton and Zung scales (p < 0.001). Comparing pre- minus post-treatment Zung scores, the sertraline plus soybean group showed a significantly higher effect than the other groups (p < 0.05). On the Hamilton scale, the combination showed significant differences versus soybean alone (p < 0.05) and sertraline alone (p < 0.05), but not versus fluoxetine.
Estrella RE, Landa AI, Lafuente JV, et al. Acta Pol Pharm, 2014. PMID 25272653
2014 / Placebo-controlled, double-blind, randomized trial
In a randomized trial, 44 young men aged 13-27 with moderate to severe ASD received daily oral sulforaphane (50-150 µmol; n=29) or placebo (n=15) for 18 weeks, followed by 4 weeks without treatment. After 18 weeks, the placebo group experienced minimal change (<3.3%), while the sulforaphane group showed a 34% decline on the ABC (P < 0.001) and a 17% decline on the SRS (P = 0.017), indicating behavioral improvement. On the CGI-I, significantly more participants receiving sulforaphane showed improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007). Scores on all scales returned toward pretreatment levels after treatment discontinuation.
Singh K, Connors SL, Macklin EA, et al. Proc Natl Acad Sci U S A, 2014. PMID 25313065
2014 / Randomized crossover trial
Researchers evaluated a low-fat plant-based diet followed by an elimination diet compared to a placebo supplement in 42 adults with migraines. Worst headache pain dropped 2.1 cm on a visual analog scale on the diet versus 0.7 cm on the supplement (p=0.03). However, reductions in headache intensity (p=0.20) and weekly frequency (p=0.61) were not significantly different between the 16-week intervention periods.
Bunner AE, Agarwal U, Gonzales JF, et al. J Headache Pain, 2014. PMID 25339342
2014 / Double-blind, placebo-controlled, randomized crossover trial
Fourteen male volunteer soldiers drank 250 ml of beverages containing 80 mg caffeine, 1000 mg taurine, both, a commercial energy drink (Red Bull), or a placebo in a randomized crossover design. Following placebo ingestion, mean values were 61.3 ± 6.2 ml/kg.min for VO2max, 196 ± 6.8 bpm for maximum heart rate, 17 ± 1.2 min for time to exhaustion, 56.8 ± 6.6 kgf for right handgrip strength, 41.1 ± 3.8 cm for vertical jump, 19.9 ± 5.9 for the Grid test, and 10.9 ± 3.1 for the Digits test. Comparisons among treatments showed no statistically significant differences in any physical or cognitive performance tests, and no adverse effects were reported.
Kammerer M, Jaramillo JA, García A, et al. J Int Soc Sports Nutr, 2014. PMID 25389379